PRIA Quarterly Review - Q1 Highlights
PRIA Healthcare • April 10, 2025
PRIA Pages is a quarterly publication highlighting PRIA Healthcare’s active involvement in key MedTech industry events. Our Q1 2025 issue includes the LSI Emerging MedTech Summit, Spine Summit, NANS Annual Meeting, and JP Morgan Healthcare Conference. It also features expert columns and workshops led by PRIA's experts in the fields of reimbursement and market access.
Click to View the PDF
Click the Icon below to share this with your network
PRIA Healthcare is thrilled to announce that Sam Murray has joined PRIA as our Head of Regulatory and Quality. Sam brings more than a decade of experience doing exactly that kind of high-stakes, high-impact regulatory work across medical devices, diagnostics, combination products, and software-enabled technologies. His
MedTech reimbursement and market access, core drivers of valuation, acquisition potential, and long-term viability, should be developed in sync with your regulatory strategy
PRIA's Second Quarter in Review
Continuing and Strengthening our Relationship with a Vital Industry Event
A leader in Reimbursement & Market Access Services, PRIA has followed developments on WISeR. Here is our summary of the new CMS Provider & Supplier Operational Guide
US Reimbursement Policy in Flux
Prior Authorization is Coming to Fee-for-Service Medicare -- What You Need to Know About CMS's Proposed WISeR Model -- a webinar from PRIA Healthcare
Why KOL Engagement is Crucial for Market Access By Tracy Davis MS, RD, Director of Market Access
In this issue of PRIA Pages, read about all that the PRIA team was up to in the MedTech industry in Q2, including LSI Asia, LSX, & Medtech Strategist's Innovation Summit!
A common pitfall that many MedTech entrepreneurs with promising technologies fall into is an assumption that if they build a superior product, customers will come.
PRIA Healthcare provides insights on optimizing Medicaid Managed Care strategies to improve reimbursement and broaden patient access. Click to learn more.
Securing commercial insurance coverage for medical technology often hinges on one critical question: How much evidence is necessary to satisfy payer requirements?
